发表于@nytopinion。杰夫·科勒写道，我们需要“使生物安全界能够以自新冠疫情以来未曾见过的速度开发应对手段——疫苗、抗体、抗病毒药物和诊断试剂”。对生物安全界来说，这是一个火烧眉毛的时刻。
In @nytopinion. We need to “enable the biosecurity community to develop countermeasures — vaccines, antibodies, antivirals and diagnostics — at a speed we haven’t seen since the Covid-19 pandemic,” Jeff Coller writes. This is a hair-on-fire moment for the biosecurity community.